Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.9B | 5.5B | 6.3B | 5.4B |
| Cost of revenue | 3.6B | 3.3B | 3.9B | 3.3B |
| Gross profit | 2.3B | 2.2B | 2.4B | 2.1B |
| Operating expense | ||||
| Research & development | 485M | 481M | 496M | 484M |
| Selling general and admin | 991M | 973M | 962M | 918M |
| Other operating expenses | 7M | 5M | 8M | 14M |
| Operating income | 844M | 697M | 946M | 679M |
| Non operating interest income | ||||
| Income | 25M | 31M | 29M | 27M |
| Expense | 104M | 108M | 142M | 116M |
| Other income expense | — | — | — | — |
| Pretax income | 730M | 617M | 844M | 595M |
| Tax provision | 194M | 138M | 221M | 122M |
| Net income | 537M | 478M | 624M | 472M |
| Basic EPS | — | 0.4 | 0.6 | 0.4 |
| Diluted EPS | — | 0.4 | 0.6 | 0.4 |
| Basic average shares | — | 1.1B | 1.1B | 1.1B |
| Diluted average shares | — | 1.1B | 1.1B | 1.1B |
| EBITDA | 1.1B | 1.0B | 1.3B | 1.0B |
| Net income from continuing op. | 537M | 478M | 624M | 472M |
| Minority interests | -6M | -4M | -7M | -4M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |